Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies

INTRODUCTION: To examine pooled efficacy data from three, large phase III studies comparing mirabegron (50 and 100 mg) with placebo, and pooled safety data including additional mirabegron 25 mg and tolterodine extended release (ER) 4 mg results. METHODS: This prespecified pooled analysis of three ra...

Full description

Saved in:
Bibliographic Details
Main Authors: Nitti, V W, Khullar, V, Kerrebroeck, P, Herschorn, S, Cambronero, J, Angulo, J C, Blauwet, M B, Dorrepaal, C, Siddiqui, E, Martin, N E
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2013
Subjects:
Urology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3752932/
https://ncbi.nlm.nih.gov/pubmed/23692526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12194
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items